Back to search
FDAFDA · Food and drugs·Recall number Z-1984-2013

Product Name: nanoPOINT Injector System, item number 37-0000-08. Intended to fold and insert a STAAR Surgical Collamer® nanoFLEX or Afinity IOLs, through surgical procedure in a human eye.

Published August 28, 2013 · Recall initiated: August 5, 2013

Summary

FDA records medical device Class II recall Z-1984-2013, published August 28, 2013 and initiated August 5, 2013. Recalling firm: Medicel Ag; Status: Terminated; Reported quantity: 68 boxes or 680 units; Lot: Item number 37-0000-08 Lot number of the recalled products: LOT121402. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The firm initiated this recall of one lot (121402) of nanoPOINT Injectors after they noticed that Tyvek lids might have been damaged and, therefore, the stability of the sterile barrier might be negatively affected.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medicel Ag
Distributor
Nationwide Distribution.
Lot
Item number 37-0000-08 Lot number of the recalled products: LOT121402
Risk classification
Class II
Area (FDA)
device
Country
Switzerland

Related recalls

Questions about this recall

Was Product Name: nanoPOINT Injector System, item number 37-0000-08. Intended to fold and insert a STAAR Surgical Collamer® nanoFLEX or Afinity IOLs, through surgical procedure in a human eye. recalled?

Yes. FDA published recall Z-1984-2013 on August 28, 2013. Reported hazard: The firm initiated this recall of one lot (121402) of nanoPOINT Injectors after they noticed that Tyvek lids might have been damaged and, therefore, the stability of the sterile barrier might be negatively affected.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail